Regenerative Medicine for Chronic Wound Healing in NYC: What's Possible

A wound that fails to progress through the normal stages of healing — hemostasis, inflammation, proliferation, and remodeling — within three months is classified as chronic. Chronic wounds represent one of the most challenging and costly problems in medicine, affecting an estimated 6.5 million patients annually in the United States. They disproportionately impact older adults, patients with diabetes, and those with venous insufficiency.

Standard wound care — debridement, moisture-retentive dressings, offloading, and infection control — succeeds in many cases. But for wounds that fail to respond, the underlying biology of impaired healing demands a different approach. At Regen Health Physicians NYC, Dr. Ajit Dhaliwal applies regenerative medicine principles to complex, non-healing wound scenarios, with particular attention to the biological deficit driving persistence.

Why Wounds Become Chronic

Normal wound healing proceeds through overlapping phases:

1. Hemostasis (minutes to hours): Platelet activation, clot formation, and initial growth factor release
2. Inflammation (days 1–4): Neutrophil and macrophage recruitment, bacterial clearance, cytokine signaling
3. Proliferation (days 4–21): Fibroblast migration, collagen deposition, angiogenesis, epithelial resurfacing
4. Remodeling (weeks to months): Collagen reorganization, scar maturation

In chronic wounds, this cascade is disrupted — most commonly at the transition from inflammation to proliferation. Chronic wounds are characterized by:

• Elevated inflammatory mediators: MMP (matrix metalloproteinase) activity degrades growth factors and collagen components as fast as they are deposited
• Cellular senescence: Fibroblasts in chronic wound beds often become senescent — metabolically active but non-proliferative
• Biofilm formation: Bacterial biofilms resist standard antibiotics and perpetuate inflammation
• Impaired angiogenesis: Diabetic wounds in particular have reduced VEGF-mediated vessel formation
• Reduced growth factor activity: Chronic wound fluid has dramatically lower concentrations of PDGF, EGF, TGF-β, and other reparative signals

Regenerative medicine aims to re-supply the biological signals the wound environment cannot generate on its own.

Regenerative Approaches at RHPNY

Platelet-Rich Plasma (PRP)

PRP delivers concentrated autologous growth factors — PDGF, VEGF, TGF-β1, EGF, FGF — directly to the wound bed. These signals:

• Stimulate fibroblast migration and proliferation
• Drive keratinocyte (epithelial cell) resurfacing
• Promote angiogenesis by activating VEGF pathways
• Modulate the local inflammatory environment

A 2019 systematic review in Wound Repair and Regeneration found PRP significantly improved healing rates in diabetic foot ulcers compared to conventional wound care. Applications include topical PRP gel applied to the wound surface, intralesional injection around wound margins, and combination with biological matrices.

Muse Cell Therapy

Muse cells (Multilineage-differentiating Stress Enduring cells) are naturally occurring pluripotent-like cells present in connective tissue throughout the body. When administered intravenously or locally, they home to sites of tissue damage — attracted by injury-induced signals — and differentiate into the specific cell type needed for repair.

In wound healing, Muse cells represent a compelling option for wounds where the regenerative cell population itself has been depleted or exhausted. RHPNY is among a select number of NYC practices offering Muse cell therapy. Learn more about our regenerative medicine approach.

Peptide Support

BPC-157 (Body Protective Compound-157) has significant data supporting wound-healing applications: upregulation of growth hormone receptors, angiogenesis promotion, and tendon/mucosal repair. For patients with concurrent GI, musculoskeletal, or systemic inflammatory pathology, BPC-157 as part of a wound healing protocol addresses both local and systemic healing capacity. See our peptide therapy services.

Exosome-Enriched Applications

Exosomes derived from mesenchymal stem cells contain the signaling cargo — growth factors, microRNAs, cytokines — that drives paracrine healing effects. Topical or intralesional exosome applications are emerging as a cell-free alternative to direct stem cell therapy in wound management.

The Chronic Wound Patient at RHPNY

Dr. Dhaliwal's wound evaluation integrates:

• Metabolic assessment: HbA1c, fasting glucose, lipids — poor glycemic control is the leading driver of diabetic wound chronicity
• Vascular assessment: Ankle-brachial index, venous Doppler — arterial and venous insufficiency must be treated concurrently
• Wound culture and biofilm assessment: Guiding antimicrobial strategy before regenerative intervention
• Nutritional status: Albumin, prealbumin, zinc, vitamin C, vitamin D — malnutrition severely impairs healing
• Offloading and pressure management: No regenerative therapy succeeds in a wound that is mechanically retraumatized daily

Regenerative interventions are layered onto a foundation of optimal wound bed preparation — not used as a substitute for it.

Who Should Consider a Regenerative Wound Consultation?

Appropriate referrals include:

• Diabetic foot ulcers that have not reduced in size by 50% after four weeks of standard care
• Venous leg ulcers unresponsive to compression therapy for three months
• Post-surgical or traumatic wounds with impaired healing
• Pressure injuries in patients with nutritional or vascular compromise

Book a consultation with RHPNY to evaluate whether regenerative wound medicine is appropriate. Our regenerative medicine services and chronic disease management programs provide the integrative foundation for complex wound management.

Medical Disclaimer

Regenerative wound care is an evolving field. PRP and advanced biological therapies are used adjunctively to — not in replacement of — evidence-based wound care standards. Outcomes vary based on wound etiology, patient health status, and compliance with the broader care plan. Consult a qualified physician before initiating any wound care intervention.